Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127396332 | 12739633 | 2 | F | 20160908 | 20160913 | 20160922 | EXP | US-ACORDA-ACO_128163_2016 | ACORDA | 0.00 | M | Y | 0.00000 | 20160922 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127396332 | 12739633 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, Q 12 HRS | 0000080105 | 22250 | 10 | MG | TABLET | Q12H | |||||
| 127396332 | 12739633 | 2 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | 100/50 MCG 1 PUFF TWICE DAILY | 0 | ||||||||||
| 127396332 | 12739633 | 3 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Oral | 1000 UNITS ONCE DAILY IN THE MORNING | U | 0 | |||||||||
| 127396332 | 12739633 | 4 | C | BACLOFEN. | BACLOFEN | 1 | Oral | 10 MG, TID | U | 0 | 10 | MG | TID | ||||||
| 127396332 | 12739633 | 5 | C | CARBIDOPA AND LEVODOPA | CARBIDOPALEVODOPA | 1 | Oral | 25 MG/100 MG THREE TIMES A DAY | U | 0 | TID | ||||||||
| 127396332 | 12739633 | 6 | C | AZILECT | RASAGILINE MESYLATE | 1 | Oral | 0.5 MG, ONCE DAILY IN THE MORNING | U | 0 | .5 | MG | |||||||
| 127396332 | 12739633 | 7 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 20 MG, ONE TABLET BY MOUTH AT BEDTIME | U | 0 | 20 | MG | |||||||
| 127396332 | 12739633 | 8 | C | COLACE | DOCUSATE SODIUM | 1 | Oral | 20 MG, ONCE AT BEDTIME | U | 0 | 20 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127396332 | 12739633 | 1 | Parkinson's disease |
| 127396332 | 12739633 | 2 | Product used for unknown indication |
| 127396332 | 12739633 | 3 | Product used for unknown indication |
| 127396332 | 12739633 | 4 | Product used for unknown indication |
| 127396332 | 12739633 | 5 | Product used for unknown indication |
| 127396332 | 12739633 | 6 | Product used for unknown indication |
| 127396332 | 12739633 | 7 | Product used for unknown indication |
| 127396332 | 12739633 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127396332 | 12739633 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127396332 | 12739633 | Asthenia | |
| 127396332 | 12739633 | Dizziness | |
| 127396332 | 12739633 | Drug interaction | |
| 127396332 | 12739633 | Fall | |
| 127396332 | 12739633 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127396332 | 12739633 | 1 | 2012 | 0 |